Colchicine, which is commonly used as an anti-inflammatory drug will be studied as a possible treatment for Covid-19 in a Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial.
The RECOVERY trial, which is the largest clinical trial of treatment for hospitalized patients due to Covid-19, will randomly allocate at least 2,500 patients who will receive the drug.
In addition, Colchicine is an interesting drug to evaluate in the trial because it is cheap and easy to find. For all you know, Colchicine costs about $ 124 for 30 capsules on the drug.com website.
According to the scientists involved in the experiment, inflammation played a key role in Covid-19 and treatment with dexamethasone, another anti-inflammatory drug, has shown that it can reduce the risk of death in the most severe patients.
Meanwhile, earlier this month, one of Britain's largest trials also studied aspirin as a painkiller as a possible treatment for Covid-19, assessing whether it could reduce the risk of blood clots in individuals with the disease.
In addition, other treatments tested in the RECOVERY trial include the common antibiotic azithromycin and Regeneron antibody cocktails used to treat the symptoms of Covid-19 US President Donald Trump.
